| IgG subclasses and allotypes: from structure to effector functions G Vidarsson, G Dekkers, T Rispens Frontiers in immunology 5, 117227, 2014 | 2890 | 2014 |
| Immunoglobulin G4: an odd antibody RC Aalberse, SO Stapel, J Schuurman, T Rispens Clinical & Experimental Allergy 39 (4), 469-477, 2009 | 1007 | 2009 |
| Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis PA Van Schouwenburg, T Rispens, GJ Wolbink Nature Reviews Rheumatology 9 (3), 164-172, 2013 | 509 | 2013 |
| Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis JF Brandse, GR van den Brink, ME Wildenberg, D van der Kleij, ... Gastroenterology 149 (2), 350-355. e2, 2015 | 429 | 2015 |
| Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities G Dekkers, L Treffers, R Plomp, AEH Bentlage, M de Boer, ... Frontiers in immunology 8, 877, 2017 | 330 | 2017 |
| The emerging importance of IgG Fab glycosylation in immunity FS van de Bovenkamp, L Hafkenscheid, T Rispens, Y Rombouts The Journal of Immunology 196 (4), 1435-1441, 2016 | 311 | 2016 |
| Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity MD Larsen, EL de Graaf, ME Sonneveld, HR Plomp, J Nouta, W Hoepel, ... Science 371 (6532), eabc8378, 2021 | 305 | 2021 |
| Key findings towards optimising adalimumab treatment: the concentration–effect curve MF Pouw, CL Krieckaert, MT Nurmohamed, D van der Kleij, L Aarden, ... Annals of the rheumatic diseases 74 (3), 513-518, 2015 | 256 | 2015 |
| Detection of infliximab levels and anti‐infliximab antibodies: a comparison of three different assays N Vande Casteele, DJ Buurman, MGG Sturkenboom, JH Kleibeuker, ... Alimentary pharmacology & therapeutics 36 (8), 765-771, 2012 | 233 | 2012 |
| A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy R Kapur, I Kustiawan, A Vestrheim, CAM Koeleman, R Visser, ... Blood, The Journal of the American Society of Hematology 123 (4), 471-480, 2014 | 226 | 2014 |
| Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation PA van Schouwenburg, LA van de Stadt, RN de Jong, EEL van Buren, ... Annals of the rheumatic diseases 72 (1), 104-109, 2013 | 226 | 2013 |
| Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis Y Rombouts, A Willemze, JJBC van Beers, J Shi, PF Kerkman, ... Annals of the rheumatic diseases 75 (3), 578-585, 2016 | 224 | 2016 |
| Affinity of human IgG subclasses to mouse Fc gamma receptors G Dekkers, AEH Bentlage, TC Stegmann, HL Howie, ... MAbs 9 (5), 767-773, 2017 | 208 | 2017 |
| Pharmacokinetic features and presence of antidrug antibodies associate with response to infliximab induction therapy in patients with moderate to severe ulcerative colitis JF Brandse, RA Mathôt, D van der Kleij, T Rispens, Y Ashruf, JM Jansen, ... Clinical Gastroenterology and Hepatology 14 (2), 251-258. e2, 2016 | 203 | 2016 |
| Differential effect of drug interference in immunogenicity assays MH Hart, H de Vrieze, D Wouters, GJ Wolbink, J Killestein, ER de Groot, ... Journal of immunological methods 372 (1-2), 196-203, 2011 | 195 | 2011 |
| Mechanism of immunoglobulin G4 Fab-arm exchange T Rispens, P Ooijevaar-de Heer, O Bende, RC Aalberse Journal of the American Chemical Society 133 (26), 10302-10311, 2011 | 181 | 2011 |
| Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis LA Trouw, T Rispens, REM Toes Nature Reviews Rheumatology 13 (6), 331-339, 2017 | 178 | 2017 |
| High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages W Hoepel, HJ Chen, CE Geyer, S Allahverdiyeva, XD Manz, SW de Taeye, ... Science translational medicine 13 (596), eabf8654, 2021 | 168 | 2021 |
| Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages LTC Vogelpoel, IS Hansen, T Rispens, FJM Muller, TMM Van Capel, ... Nature communications 5 (1), 5444, 2014 | 165 | 2014 |
| Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies L Boekel, M Steenhuis, F Hooijberg, YR Besten, ZLE van Kempen, ... The Lancet Rheumatology 3 (11), e778-e788, 2021 | 157 | 2021 |
